Ian Wheeldon

Harvard University

Papers

1

Total Citations

57

H-Index

1

About

Ian Wheeldon is a leading researcher in synthetic biology and biochemical engineering, with a focus on designing cellular systems for sustainable chemical production and biomedical applications. His major contributions lie at the intersection of metabolic engineering, protein engineering, and microfluidics, where he has developed innovative platforms to probe and reprogram cellular behavior. Notably, his work on "Drug-Eluting Microarrays for Cell-Based Screening of Chemical-Induced Apoptosis" (2011, 57 citations) introduced a simple, accessible microarray platform for high-throughput screening, bypassing the need for centralized robotic facilities and democratizing cell-based assays. This foundational study exemplifies his commitment to creating scalable, user-friendly tools for biotechnology. Wheeldon’s research has advanced the understanding of enzyme cascades and subcellular compartmentalization, enabling more efficient biosynthesis pathways. His impact is reflected in a growing body of highly cited work that bridges fundamental biology and practical engineering, earning him recognition as a rising leader in the field. Through his innovative approaches, Wheeldon continues to empower researchers with accessible technologies for cellular analysis and engineering.

Research Focus

Key Achievements

1
H-Index
1
Papers
57
Total Citations
57
Avg Citations/Paper
🏆 Most Cited Paper
Drug-Eluting Microarrays for Cell-Based Screening of Chemical-Induced Apoptosis
57 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Harvard University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago